Jim Simons Harrow Health, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Harrow Health, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 293,770 shares of HROW stock, worth $9.99 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

293,770

Previous 306,208 4.06%

Holding current value

$9.99 Million

Previous $6.4 Million 106.49%

% of portfolio

0.02%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$20.85 - $46.47 $259,332 - $577,993	-12,438 Reduced 4.06%	293,770 $13.2 Million
Q2 2024 Aug 09, 2024	SELL	$10.0 - $21.64 $1.71 Million - $3.7 Million	-171,150 Reduced 35.85%	306,208 $6.4 Million
Q1 2024 May 13, 2024	SELL	$9.3 - $13.23 $1.24 Million - $1.77 Million	-133,822 Reduced 21.9%	477,358 $6.32 Million
Q4 2023 Feb 13, 2024	SELL	$8.1 - $16.36 $2.75 Million - $5.56 Million	-339,878 Reduced 35.74%	611,180 $6.85 Million
Q3 2023 Nov 14, 2023	BUY	$14.03 - $22.08 $838,236 - $1.32 Million	59,746 Added 6.7%	951,058 $13.7 Million
Q2 2023 Aug 11, 2023	SELL	$17.37 - $28.08 $1.24 Million - $2 Million	-71,300 Reduced 7.41%	891,312 $17 Million
Q1 2023 May 12, 2023	SELL	$13.84 - $21.46 $2.34 Million - $3.63 Million	-169,375 Reduced 14.96%	962,612 $20.4 Million
Q4 2022 Feb 13, 2023	BUY	$10.28 - $14.78 $199,175 - $286,362	19,375 Added 1.74%	1,131,987 $16.7 Million
Q3 2022 Nov 14, 2022	SELL	$6.57 - $24.88 $362,664 - $1.37 Million	-55,200 Reduced 4.73%	1,112,612 $13.4 Million
Q2 2022 Aug 12, 2022	BUY	$5.75 - $7.74 $453,692 - $610,709	78,903 Added 7.25%	1,167,812 $8.5 Million
Q1 2022 May 13, 2022	SELL	$6.77 - $8.66 $746,074 - $954,357	-110,203 Reduced 9.19%	1,088,909 $7.43 Million
Q4 2021 Feb 11, 2022	SELL	$8.5 - $12.0 $586,500 - $828,000	-69,000 Reduced 5.44%	1,199,112 $10.4 Million
Q3 2021 Nov 12, 2021	SELL	$6.99 - $10.6 $918,486 - $1.39 Million	-131,400 Reduced 9.39%	1,268,112 $11.5 Million
Q2 2021 Aug 13, 2021	SELL	$6.68 - $11.07 $1.1 Million - $1.82 Million	-164,700 Reduced 10.53%	1,399,512 $13 Million
Q1 2021 May 13, 2021	BUY	$6.26 - $11.03 $444,460 - $783,130	71,000 Added 4.75%	1,564,212 $10.6 Million
Q4 2020 Feb 10, 2021	BUY	$4.76 - $6.93 $760,329 - $1.11 Million	159,733 Added 11.98%	1,493,212 $10.2 Million
Q3 2020 Nov 13, 2020	BUY	$4.71 - $7.36 $88,548 - $138,368	18,800 Added 1.43%	1,333,479 $7.45 Million
Q2 2020 Aug 13, 2020	BUY	$3.61 - $6.47 $8,927 - $16,000	2,473 Added 0.19%	1,314,679 $6.85 Million
Q1 2020 May 14, 2020	BUY	$3.5 - $7.31 $266,000 - $555,560	76,000 Added 6.15%	1,312,206 $5.01 Million
Q4 2019 Feb 13, 2020	SELL	$4.6 - $7.88 $75,900 - $130,020	-16,500 Reduced 1.32%	1,236,206 $9.62 Million
Q3 2019 Nov 13, 2019	BUY	$4.89 - $8.0 $519,317 - $849,600	106,200 Added 9.26%	1,252,706 $7.04 Million
Q2 2019 Aug 12, 2019	BUY	$4.2 - $8.7 $750,540 - $1.55 Million	178,700 Added 18.46%	1,146,506 $9.98 Million
Q1 2019 May 14, 2019	BUY	$4.75 - $7.1 $4.6 Million - $6.87 Million	967,806 New	967,806 $4.82 Million

Others Institutions Holding HROW

# of Institutions

176

Shares Held

21.4M

Call Options Held

845K

Put Options Held

717K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $921M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account